The Asia-Pacific respiratory device market was valued at around $6.1 billion in 2018 and is estimated to grow at a CAGR of around 6.7% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in North America. The Asia-Pacific respiratory devices market presents future opportunities for growth as the prevalence of respiratory diseases such as asthma and COPD in emerging economies such as India and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growing market.
The Asia-Pacific respiratory device market is segmented on the basis of product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. The therapeutic devices segment is estimated to dominate the regional market and is also anticipated to grow at the fastest growth rate over the forecast period. The high cost of therapeutics device and significant demand for continuous positive airway pressure (CPAP) devices and masks, ventilator, oxygen concentrator, and oxygen hoods contribute majorly to the segmental growth of the market for therapeutic devices. Based on end-user, the market is analyzed into hospitals and clinics, and home care.
Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region. Some of the key players of the market include ResMed Corp., Cipla Ltd., GlaxoSmithKline PLC, 3M Co., Novartis AG, Omron Healthcare Inc., and others. The market players are adopting the strategy of merger & acquisition, product launch and expansion of their manufacturing facilities to increase their market share. For instance, In January 2018 Omron Healthcare Introduces Avail, a Wireless Device for Drug-Free Pain Relief. In January 2019 Omron Healthcare officially launches HeartGuide the first wearable blood pressure monitor, with new digital health service, HeartAdvisor.
Research Methodology
The market study of the Asia-Pacific respiratory device market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include:
The report is intended for respiratory device manufacturers, contract research organizations (CROs), the healthcare sector, market research firms, and government organizations, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation:
The Report covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Asia-Pacific Respiratory Device Market by Product
5.1.1. Therapeutic Devices
5.1.2. Diagnostic and Monitoring Devices
5.1.3. Consumables and Accessories
5.2. Asia-Pacific Respiratory Device Market by End-User
5.2.1. Homecare
5.2.2. Hospitals and Clinics
6. Regional Analysis
6.1. China
6.2. Japan
6.3. India
6.4. Rest of Asia-Pacific
7. Company Profiles
7.1. 3M Co.
7.2. Acorda Therapeutics, Inc.
7.3. Adamis Pharmaceuticals Corp.
7.4. Adherium Ltd.
7.5. Aradigm Corp.
7.6. AstraZeneca PLC
7.7. Beximo Pharmaceuticals Ltd.
7.8. BMC Medical Co., Ltd.
7.9. Boehringer Ingelheim International GmbH
7.10. Cipla Ltd.
7.11. GlaxoSmithKline PLC
7.12. Koninklijke Philips N.V.
7.13. MidasCare Pharmaceutical Pvt. Ltd.
7.14. Mylan N.V.
7.15. Novartis AG
7.16. Omron Healthcare Inc.
7.17. ResMed Corp.
7.18. Sunovion Pharmaceuticals
7.19. Teijin Pharma Ltd.
7.20. Teva Pharmaceuticals Industries Ltd.
1. ASIA-PACIFIC RESPIRATORY DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
2. ASIA-PACIFIC RESPIRATORY DEVICE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
3. ASIA-PACIFIC RESPIRATORY DEVICE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
1. ASIA-PACIFIC RESPIRATORY DEVICE MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
2. ASIA-PACIFIC RESPIRATORY DEVICE MARKET SHARE BY END-USER, 2018 VS 2025 (%)
3. CHINA RESPIRATORY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
4. JAPAN RESPIRATORY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
5. INDIA RESPIRATORY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)
6. REST OF ASIA-PACIFIC RESPIRATORY DEVICE MARKET SIZE, 2018-2025 ($ MILLION)